LIAISON LYMEDETECT
LIVE

Serial Number

79300833

Owner

DIASORIN S.P.A.

Attorney

Jeffrey B. Sladkus, Esq.

Filing Date

Aug 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LIAISON LYMEDETECT Trademark

Serial Number: 79300833 • Registration: 6532877

LIAISON LYMEDETECT is a trademark filed by DIASORIN S.P.A. on August 26, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

DIASORIN S.P.A. (15 trademarks)

VIA CRESCENTINO SNC
SALUGGIA, VERCELLI 13040 , IT

Entity Type: 09

Trademark Details

Filing Date

August 26, 2020

Registration Date

October 26, 2021

Published for Opposition

August 10, 2021

Goods & Services

Scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; laboratory apparatus and instruments for conducting and evaluating diagnostic examinations for medical purposes, and parts and fittings therefor, namely, microscopes, microscope slides; diagnostic instruments for scientific purposes in the nature of diagnostic apparatus for testing food; diagnostic testing apparatus for scientific and research testing being diagnostic apparatus for testing food; computer systems comprising of computer hardware and downloadable computer software for collecting, storing, analysing and reporting biological information, and for sample tracking and managing projects, laboratory workflows and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes; downloadable software for use with electronic medical and diagnostic apparatus; downloadable software and downloadable software containing algorithms, in particular downloadable computer databases, for helping to make medical decisions or carry out research, for diagnostic and therapeutic applications; computer hardware for medical and diagnostic tasks; devices in the nature of computer hardware for generating images for detecting, quantifying and linking biological or chemical molecules; liquid analyzers; laboratory instruments, namely, genome sequencers being laboratory devices for detecting genetic sequences; specimen containers, namely, petri dishes

Diagnostic preparations for medical purposes; diagnostic substances for medical purposes; diagnostic reagents for use in diagnostic tests for medical purposes; chemical preparations for testing blood for medical purposes; chemical preparations for testing blood for veterinary purposes; in vitro diagnostic preparations for medical purposes; in vitro diagnostic preparations for veterinary purposes; chemicals reagents for testing DNA for medical purposes; nucleic acid sequences for medical and veterinary purposes; diagnostic reagents for use in diagnostic tests for veterinary purposes; reactants for medical diagnosis being diagnostic preparations for medical purposes; clinical medical diagnostic reagents; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; indicators for medical diagnosis being diagnostic preparations for medical purposes; diagnostic substances for medical use; diagnostic substances for veterinary use; medicated antiserums for diagnostic purposes for diagnosing skin conditions; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; reagents for microbiological analysis for medical purposes; reagents for microbiological analysis for veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; diagnostic chemical reagents for medical use; diagnostic chemical reagents for veterinary use; medical diagnostic reagents and assays for testing of body fluids; diagnostic agents for pharmaceutical use; test strips for measuring blood glucose levels; medical diagnostic test strips for monitoring blood sugar levels; medical diagnostic kits comprising diagnostic reagents for extracting, testing and analyzing body fluids, nucleic acids, DNA, RNA; medical diagnostic kits comprising diagnostic reagents for extracting, isolating, testing and analyzing blood cells; test strips containing medical diagnostic reagents for measuring blood glucose levels

Diagnostic preparations for scientific or research use; diagnostic reagents and chemical reagents, for laboratory or research use, not for medicinal purposes; blood glucose control solutions used in diagnostic test kits, for laboratory or research use; diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs for laboratory use; scientific chemical products for diagnostic use in the nature of chemical test paper; chemical and reagent solutions being chemical reagents used in diagnostic test kits, not for medical purposes; diagnostic biomarker reagents for analytical, research and scientific use; assays and reagents for use in genetic research; chemically treated test strips, other than for medical purposes for testing the pH of liquids; chromatography chemicals for laboratory use; reagents for use in scientific apparatus for chemical or biological analysis for testing the presence of antigens in blood, human serum, plasma, urine, other biological fluids, and tissue; chemically treated non-medical test strips for detecting alcohol and drugs

Kits for medical diagnostic applications in the nature of medical test kits for diabetes monitoring for home use; apparatus for carrying out medical diagnoses, in particular fluorescence diagnostic apparatus and instruments used for the purpose of identifying infectious diseases and the severity thereof being medical diagnostic apparatus for detecting cancer; electromagnetic medical diagnostic imaging apparatus for medical use; electromagnetic medical diagnostic imaging apparatus for medical purposes containing fluorimeters used to register fluorescence signals and produce data; diagnostic lasers for medical purposes; medical and diagnostic devices, apparatus and/or equipment for molecular analysis being medical diagnostic apparatus for testing DNA and RNA samples; scanners for medical diagnosis, namely, x-ray CT scanners; blood spectrum analyzers for use in medical diagnosis; ultrasonic medical diagnostic apparatus; magnetic field generators for medical purposes, namely, magnetic resonance imaging apparatus for medical purposes; electromagnetic medical diagnostic imaging apparatus; optical instruments for medical diagnostics in the nature of optometric instruments for locating the optical center of ophthalmic lenses; containers for sample analysis, syringes and plungers being containers for medical waste; sampling vials of plastic or other materials being blood sampling tubes; preparation vials of plastic or other materials being blood sampling tubes; devices containing reagents for medical diagnostic test use, namely, capillary reagent tubes; test devices containing chemical reagents for in-vitro diagnostic medical testing being sample preparation device for medical diagnostic uses

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 9, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 19, 2022 FICS
FINAL DISPOSITION PROCESSED
Apr 19, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 26, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 26, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Aug 15, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 10, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 10, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 28, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 28, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 21, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 1, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2021 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 15, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 15, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 15, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 15, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 15, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 15, 2021 COAR
REFUSAL PROCESSED BY IB
Feb 14, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 25, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 25, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 5, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 4, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 1, 2021 MAFR
ASSIGNED TO EXAMINER
Dec 28, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 24, 2020 REPR